Maugel Designs Biopharmaceutical Facility for LFB

by: Robin Peters, Marketing Director
Thu, Jan 26 , 2017


Maugel Architects, Inc. of Harvard, MA announced the design of the new $37 million manufacturing facility for LFB USA.  LFB USA, a leading biopharmaceutical firm, is a unit of France’s LFB Group.  Located on Crowley Drive, the facility will produce the drug ATryn used in the treatment of preeclampsia, a leading cause of maternal and infant death.

The 70,000sf facility will house 30,000sf of clean room manufacturing space, 20,000sf of warehouse space, and 14,000sf of office space.  Maugel worked closely with the client and the consulting process engineer to ensure the clean room manufacturing was efficient and state-of-the-art.  A distinct modern aesthetic was designed for the building’s exterior.

“LFB’s addition to Marlborough’s expanding biotech cluster reinforces the positive outlook for the MetroWest region,” said Jon Cocker, institutional studio head at Maugel Architects.  “For more than two decades, Maugel has been designing labs and life sciences facilities in the Boston suburbs. It was a pleasure working with LFB on this exciting new facility in MetroWest.”

In addition to Maugel Architects, other team members included R.P. Masiello, Whitman & Bingham Associates, TF Moran, Inc., William F. Lynch Co., Inc., Shepherd Engineering, and SNC-Lavalin Project Services.